Viewing Study NCT03345134


Ignite Creation Date: 2025-12-25 @ 2:29 AM
Ignite Modification Date: 2026-05-06 @ 8:44 PM
Study NCT ID: NCT03345134
Status: NOT_YET_RECRUITING
Last Update Posted: 2017-11-17
First Post: 2017-11-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without Nephroureterectomy
Sponsor: Shaheen Alanee
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None High Risk Superficial Upper Urinary Tract Transitional Cell Carcinoma View
None Endoscopic Surgical Procedure View
None Transitional Epithelial Cells View
Keywords: